Further characterization of the binding of human recombinant interleukin 2 to heparin and identification of putative binding sites

Glycobiology

Volumn 8, Issue 5, 1998, Pages 509-516

  Najjam, Saloua ^a   Mulloy, Barbara ^b   Theze, Jacques ^c   Gordon, Myrtle ^d   Gibbs, Roslyn ^e   Rider, Christopher C ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

^c INSTITUT PASTEUR   (France)

^d IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^e UNIVERSITY OF PORTSMOUTH   (United Kingdom)

Author keywords

Cytokine; Heparin; IL 2; IL 2 receptor; Monoclonal antibodies

Indexed keywords

HEPARIN; HEPARIN FRAGMENT; INTERLEUKIN 2 DERIVATIVE; INTERLEUKIN 2 RECEPTOR; RECOMBINANT INTERLEUKIN 2;

AMINO ACID SEQUENCE; ARTICLE; BINDING AFFINITY; BINDING SITE; ENZYME LINKED IMMUNOSORBENT ASSAY; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION;

ANIMALS; ANTIBODIES, MONOCLONAL; BINDING SITES; CARBOHYDRATE CONFORMATION; CELL DIVISION; CELL LINE; CRYSTALLOGRAPHY, X-RAY; HEPARIN; HUMANS; INTERLEUKIN-2; KINETICS; MODELS, MOLECULAR; PROTEIN CONFORMATION; RECOMBINANT PROTEINS; SWINE;

EID: 0031798591     PISSN: 09596658     EISSN: None     Source Type: Journal    
DOI: 10.1093/glycob/8.5.509     Document Type: Article

References (41)

1. Bamborough, P. Hedgecock, C.J.R. and Richards, W.G. (1994) The interleukin-2 and interleukin-4 receptors studied by molecular modelling. Structure (London), 2, 677-682.
2. Bazan, J.F. and McKay, D.B. (1992) Unraveling the structure of IL-2. Science, 257, 410-413.
3. Buchli, P. and Ciardelli, T.L. (1993) Structural and biologic properties of human aspartic acid-126 interleukin-2 analog. Arch. Biochem. Biophys., 307, 411-415.
4. Chang, D.Z., Tasayco, M-L. and Ciardelli, T.L. (1995) Structural analogs of interleukin-2: a point mutation that facilitates biological response. Mol. Pharmacol., 47, 206-211.
5. Eckenberg, R., Xu, D., Moreau, J-L., Bossus, M., Mazies, J-C., Tartar, A.., Liu, X.Y., Bertoglio, J. and Theze, J. (1997) Monoclonal antibody H2-8 and new IL-2 mutants at positions 17 and 20 establish the critical role of α helix A in human IL-2/TL-2 receptor β chain interactions. Cytokine, 9, 488-498.
6. Faham, S., Hileman, R.E., Fromm, J.R., Linhardt, R.J. and Rees, D.C. (1996) Heparin structure and interactions with basic fibroblast growth factor. Science, 271, 1116-1119.
7. Gallagher, J.T., Lyon, M. and Steward, W.P. (1986) Structure and function of heparan sulfate proteoglycans. Biochem. J., 236, 313-325.
8. Gillis, S., Ferm, M.M., Ou, W. and Smith, J. (1978) T-Cell growth factor: parameters of production and a quantitative microassay for activity. J. Immunol., 120, 2027-2032.
9. Hampson, I.N. and Gallagher, J.T. (1984) Separation of radiolabelled glycosaminoglycan oligosaccharides by polyacrylamide-gel electrophoresis. Biochem. J., 221, 697-705.
10. Ishihara, M., Tyrrel, D.L., Stauber, G.B., Brown, S., Cousens, L.S. and Stack, R.J. (1993) Preparation of affinity-fractionated, heparin-derived oligosaccharides and their effects on selected biological activities mediated by basic fibroblast growth factor. J. Biol. Chem., 268, 4675-4683.
11. Johnson, E.A. (1984) Heparan sulfates from porcine intestinal mucosa. Preparation and physiochemical properties. Thrombosis Res., 35, 583-588.
12. Jordan, E.J., Favreau, L.V., Braswell, E.H. and Rosenberg, R.D. (1982) Heparin with two binding sites for antithrombin or platelet factor 4. J. Biol. Chem., 257, 400-406.
13. Ju, G., Collins, L., Kaffka, K.L., Tsein, W-H., Chizzonite, R., Crowl, R., Bhatt, R. and Killian, P.L. (1987) Structure-function analysis of human interleukin-2. Identification of amino acid residues required for biological activity. J. Biol. Chem., 262, 5723-5731.
14. Kolset, S.O. and Gallagher, J.T. (1990) Proteoglycans in haemopoietic cells. Biochem. Biophys. Acta, 1032, 191-211.
15. Lindahl, U., Thunberg, L., Backstrom, G., Reisenfeld, J., Nordling, K., and Bjork, I. (1984) Extension and structural variability of the antithrombin-binding sequence in heparin. J. Biol. Chem., 259, 12368-12376.
16. Lortat-Jacob, H., Baltzer, F. and Grimaud, J-A. (1996) Heparin decreases the blood clearance of interferon-γand increases its activity by limiting the processing of its carboxyl-terminal sequesence. J. Biol. Chem., 271, 16139-16143.
17. Maccarana, M., Casu, B. and Lindahl, U. (1993) Minimal sequence in heparin/heparan sulfate required for binding of basic fibroblast growth factor. J. Biol. Chem., 268, 23898-23905.
18. Mann, D.M., Romm, E. and Migliorini, M. (1994) Delineation of the glycosaminoglycan-binding site in the human inflammatory response protein lactoferrin. J. Biol. Chem., 269, 23661-23667.
19. Minami, Y., Kono, T., Miyazaki, T. and Taniguchi, T. (1993) The IL-2 receptor complex: its structure, function and target genes. Annu. Rev. Immunol., 11, 245-267.
20. Moreau, J-L., Bossus, M., Groote, D., Francois, C., Jacques, Y., Tartar, A. and Theze, J. (1995) Characterization of a monoclonal antibody directed against the NH2 terminal area of interleukin-2 (IL-2) and inhibiting specifically the binding of IL-2 to IL-2 receptor b chain (IL-2Rb). Mol. Immunol., 32, 1047-1056.
21. Mott, H.R., Baines, B.S., Hall, R.M., Cooke, R.M., Driscoll, P.C., Weir, M.P. and Campbell, L.D. (1995) The solution structure of the F42A mutant of human interleukin 2. J. Mol. Biol., 247, 979-994.
22. Mulloy, B., Forster, M.J., Jones, C., Drake, A.F., and Davies, D.B. (1993) NMR and molecular modelling studies of the solution conformation of heparin. Biochem. J., 293, 849-858.
23. Mulloy, B., Gee, C., Wheeler, S.F., Wait, R., Gray, E. and Barrowcliffe, T.W. (1997) Molecular weight measurment of low molecular weight heparins by gel permeation chromatography. Throm. Haemostasis, 77, 668-676.
24. Myszka, D.G., Arulanantham, P.R., Sana, T., Wu, Z., Morton, T.A. and Ciardelli, T.L. (1996) Kinetic analysis of ligand binding to interleukin-2 receptor complexes created on an optical biosensor surface. Protein Sci., 5, 2468-2478.
25. Najjam, S., Gibbs, R.V., Gordon, M.Y. and Rider, C.C. (1997) Characterisation of human recombinant interleukin 2 binding to heparin and heparan sulfate using an ELISA approach. Cytokine, 9, 1013-1022.
26. Ramsden, L. and Rider, C.C. (1992) Selective and differential binding of interleukin (IL)-1α. IL-1β, IL-2 and IL-6 to glycosaminoglycans. Eur. J. Immunol., 22, 3027-3031.
27. Rapraeger, A.C., Krufka, A. and Olwin, B.B. (1991) Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science, 252, 1705-1708.
28. Rebollo, A., De Groote, D., Baudrihay, M., Theze, J. and Jankovic, D. (1992) Immunochemical characterization of antigenic domains on human IL-2: spatially distinct epitopes are associated with binding to the p55 and p75 subunits of IL-2 receptor. Mol. Immunol., 29, 119-130.
29. Rider, C.C., Coombe, D.R., Harrop, H.A., Hounsell, E.F., Bauer, C., Feeney, J., Mulloy, B., Mahmood, N., Hay, A. and Parish, C.R. (1994) Anti-HIV-1 activity of chemically modified heparins: correlation between binding to the V3 loop and inhibition of cellular HIV-1 infection in vitro. Biochemisty, 33, 6974-6980.
30. Rider, C.C. (1998) Analysis of glycosaminoglycans and proteoglycans. In Hounsell, E.F. (eds), Glycoanalysis: Analysis Protocols For Glycosylated Molecules. Methods in Molecular Biology, 76. Humana Press, New Jersey, in press.
31. Saksela, O., Moscatelli, D., Sommer, A. and Rifkin, D.B. (1988) Endothelial cell-derived heparan sulfate binds fibroblast growth factor and protects it from proteolytic degradation. J. Cell Biol., 107, 743-751.
32. Sauve, K., Nachman, M., Spence, C., Bailon, P., Campbell, E., Tsien, W-H., Kondas, J.A., Hakimi, J. and Ju, G. (1991) Localization in human interleukin 2 of the binding site to the a chain (p55) of the interleukin 2 receptor. Immunology, 88, 4636-4640.
33. Schlessinger, J., Lax, I. and Lemmon, M. (1995) Regulation of growth factor activation by proteoglycans : what is the role of low affinity receptors? Cell, 83, 357-360.
34. Spillman, D. and Lindahl, U. (1994) Glycosaminoglycan-protein interactions: a question of specificity. Curr. Opinion Struct. Biol., 4, 677-682.
35. Taniguchi, T., Matsui, H., Fujita, T., Hatakeyama, M., Kashima, N., Fuse, A., Hamuro, J., Nishi-Takaoka, C. and Yamada, G. (1986) Molecular analysis of the interleukin-2 system. Immunol. Rev., 92, 121-133.
36. Theze, J., Alzari, P.M. and Bertoglio, J. (1996) Interleukin 2 and its receptors: recent advances and new immunological functions. Immunol. Today, 17, 481-486.
37. Thompson, L.D., Pantoliano, M.W. and Springer, B.A. (1994) Energetic characterization of the basic fibroblast growth factor-heparin interaction: identification of the heparin binding domain. Biochemistry, 33, 3831-3840.
38. Turnbull, J.E., Fernig, D.G., Ke, Y., Wilkinson, M.C. and Gallagher, J.T. (1992) Identification of the basic growth factor sequence in fibroblast heparan sulfate. J. Biol. Chem., 267, 10337-10341.
39. Yanagashita, M. and Hascall, V.C. (1992) Cell surface heparan sulfate proteoglycans. J. Biol. Chem., 267, 9451-9454.
40. Yayon, A., Klagsbrun, M., Esko, J.D., Leder, P. and Ornitz, D.M. (1991) Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell, 64, 841-848.
41. Zurawski, S.M., and Zurawski, G. (1992) Receptor antagonist and selective agonist derivatives of mouse interleukin 2. EMBO J., 11, 3905-3910.